ResearchResearch summary
Recurrent vaginal yeast infection: lived experience
Interviews with 10 trial-screened women in Australia describe recurrent vaginal yeast infection experiences; the themes are not population rates or treatment effects.
In this pathway
- Current topic
- Recurrent vaginal yeast infection: lived experienceCurrent
Bottom line
Ten Australian women described living with confirmed recurrent vaginal yeast infection. Their accounts add context, but do not show how common these experiences are or what care works.
Why this source matters
The interviews add patient perspectives on diagnosis delays, support, self-education, and personal impact alongside quantitative quality-of-life research and a separate diagnostic-experience study.
Study and population
The study interviewed ten English-speaking, pre-menopausal women aged 18–44 in Australia with confirmed idiopathic RVVC. They had recently been screened for an Australian national RVVC clinical trial.
What was tested
There was no assigned treatment, comparison group, or diagnostic test. Researchers conducted one-to-one semi-structured interviews from April to July 2021 and analyzed the accounts using interpretative phenomenological analysis.
Results
The analysis identified four themes: challenges with diagnosis and management; perceived limits in health-professional knowledge; lack of support leading to self-education and self-referral; and emotional and psychosocial repercussions. Interview accounts included recalled diagnosis delays of 9 to 48 months. That range describes accounts in this selected sample, not a typical delay. Participants also described effects on intimacy, relationships, work and social life, finances, and repeated self-management.
Applicability
The findings offer context about the experiences of this small group of women with confirmed RVVC in Australia. They do not establish how other people experience recurrence or describe care in other countries.
Limitations
The sample was small and recruited after clinical-trial screening. Participants were motivated to seek answers, and the authors note that people with delayed diagnosis or difficult management may be overrepresented. The study reports themes rather than measured effects, does not assess health-professional perspectives, and cannot establish frequency, causation, treatment effectiveness, diagnostic accuracy, or crisis risk.
Contribution to the evidence
Contextual. The interviews deepen the description of patient experience but do not change the larger evidence-based conclusions about diagnosis, treatment, or safety.
Practical change
No practical change. The study did not test an appointment tool, care pathway, treatment, or crisis trigger; existing diagnostic and safety guidance remains in place.
Funding and conflicts
The authors reported no project funding and declared no competing interests.
Source
Read the original publication (published 19 September 2022).
Study type, population, and sample scale
- Study type
- Exploratory qualitative study using semi-structured interviews and interpretative phenomenological analysis (IPA)
- Population
- Ten English-speaking, pre-menopausal women aged 18–44 in Australia with confirmed idiopathic RVVC, recruited after recent screening for a national RVVC clinical trial
- Sample scale
- 10 women completed interviews; 28 trial-screened women were eligible, 12 completed the pre-interview survey, and 2 chose not to proceed to interview
Results
- Ten interviews generated four themes—diagnosis and management challenges, perceived health-professional knowledge limitations, lack of support linked with self-education and self-referral, and emotional and psychosocial repercussions.
- Interview accounts included recalled diagnosis delays ranging from 9 to 48 months. This is a sample-specific recalled range, not an estimate of usual delay.
- Participants described effects on intimacy, relationships, work or social life, finances, and repeated self-management; the study did not use a validated distress measure or estimate how often these experiences occur in the wider population.
Limitations
- The themes and diagnosis-delay range come from ten interviewees.
- Participants had recently been screened for a national RVVC trial and were motivated to seek answers; the authors note they may overrepresent delayed diagnosis or problematic management, so the accounts are not population frequencies.
- Participants described emotional and psychosocial effects and perceived gaps in care.
- The study had no comparison group, validated distress measure, or assessment of health-professional experience and cannot establish prevalence, causation, care quality, or individual prediction.
- All interviewees were English-speaking and pre-menopausal women aged 18–44 in Australia with confirmed idiopathic RVVC.
- The small, single-country sample limits transfer to other populations and health systems.
Applies to
- Context on how a small group of women with confirmed idiopathic RVVC in Australia described diagnosis, care, and personal impact
Does not apply to
- Estimating how common delays, stigma, or emotional effects are among people with RVVC
- Establishing treatment effectiveness, diagnostic accuracy, comparative care quality, medication safety, or crisis risk
- Assuming the accounts represent people outside this English-speaking, pre-menopausal, trial-screened Australian sample
Contribution to the current conclusion
Contextual
This small, selected Australian interview study adds detail about patient-reported diagnosis and care experiences, but it provides no population estimate, treatment comparison, diagnostic evaluation, or validated crisis predictor and does not change current claims or actions.
Related evidence mapPractical change or no change
No practical change. The interviews do not test a care action, tool, treatment, or safety trigger; current diagnostic and safety guidance remains unchanged.
Funding and conflicts
- Funding
- The authors reported that the project had no funding.
- Conflicts
- The authors declared no competing interests.
- Paper date
- 2022-09-19
Sources
View all 1 source
- Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey
- Source type
- Observational study
- Published
- 2022-09-19